Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Expert Review of Hematology|July 17, 2024
Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?Caterina Alati, Martina Pitea, Maria Caterina Mico, et al.
Diseases (Basel, Switzerland)|December 24, 2025
Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell TransplantationGaetana Porto, Annalisa Pitino, Mercedes Gori, et al.
Cancers|June 2, 2021
CART-Cell Therapy: Recent Advances and New Evidence in Multiple MyelomaMassimo Martino, Filippo Antonio Canale, Caterina Alati, et al.
Annals of Hematology|December 20, 2019
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplantMassimo Martino, Mercedes Gori, Giovanni Tripepi, et al.
Annals of Hematology|April 20, 2023
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantationMassimo Martino, Mercedes Gori, Gaetana Porto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 4, 2021
Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experienceBarbara Loteta, Annalisa Paviglianiti, Virginia Naso, et al.
Cancers|October 16, 2024
First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center StudyMassimo Martino, Mercedes Gori, Gaetana Porto, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Blood Advances|February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trialAnna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
Pageof 3